当前位置:首页 - 行情中心 - 赛托生物(300583) - 财务分析 - 现金流量表

赛托生物

(300583)

  

流通市值:27.12亿  总市值:27.64亿
流通股本:1.86亿   总股本:1.90亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金328,861,563.01133,668,649.63822,928,510.35554,251,040.59
  收到的税费返还2,952,789.18711,754.212,509,418.6410,095,964.54
  收到其他与经营活动有关的现金68,114,536.950,821,607.4843,206,302.2443,539,007.17
  经营活动现金流入小计399,928,889.09185,202,011.31878,644,231.23607,886,012.3
  购买商品、接受劳务支付的现金188,443,992.38112,102,535.42350,267,677.45193,853,083.11
  支付给职工以及为职工支付的现金56,656,372.0726,847,411.16133,692,077.12107,492,011
  支付的各项税费14,412,460.344,897,590.9856,655,247.4340,831,372.48
  支付其他与经营活动有关的现金77,734,441.5851,625,688.51143,569,639.9596,698,381.8
  经营活动现金流出小计337,247,266.37195,473,226.07684,184,641.95438,874,848.39
  经营活动产生的现金流量净额62,681,622.72-10,271,214.76194,459,589.28169,011,163.91
二、投资活动产生的现金流量:
  收回投资收到的现金--3,000,000-
  取得投资收益收到的现金4,130,021.224,130,021.22--
  处置固定资产、无形资产和其他长期资产收回的现金净额7,500-245,10046,100
  处置子公司及其他营业单位收到的现金净额--07.82
  收到的其他与投资活动有关的现金--5,711,0002,311,000
  投资活动现金流入小计4,137,521.224,130,021.228,956,1002,357,107.82
  购建固定资产、无形资产和其他长期资产支付的现金24,210,984.8215,219,229.7165,525,541.6663,661,566.23
  支付其他与投资活动有关的现金--744,785.48-
  投资活动现金流出小计24,210,984.8215,219,229.7166,270,327.1463,661,566.23
  投资活动产生的现金流量净额-20,073,463.6-11,089,208.49-57,314,227.14-61,304,458.41
三、筹资活动产生的现金流量:
  取得借款收到的现金415,240,232.3285,240,232.31,062,903,756.01705,723,756.01
  收到其他与筹资活动有关的现金35,770,95036,000,00048,500,00048,500,000
  筹资活动现金流入小计451,011,182.3321,240,232.31,111,403,756.01754,223,756.01
  偿还债务支付的现金401,240,120.45270,340,890.961,079,668,280.42772,591,320.68
  分配股利、利润或偿付利息支付的现金16,024,842.687,630,857.18112,853,418.76107,178,097.51
  支付其他与筹资活动有关的现金22,550,592.8619,855,343.7281,918,788.5766,452,355.92
  筹资活动现金流出小计439,815,555.99297,827,091.861,274,440,487.75946,221,774.11
  筹资活动产生的现金流量净额11,195,626.3123,413,140.44-163,036,731.74-191,998,018.1
四、汇率变动对现金及现金等价物的影响-934,046.34-2,486,213.771,247,586.11-950,262.96
五、现金及现金等价物净增加额52,869,739.09-433,496.58-24,643,783.49-85,241,575.56
  加:期初现金及现金等价物余额155,489,721.02174,140,853.47180,133,504.51180,133,504.51
  期末现金及现金等价物余额208,359,460.11173,707,356.89155,489,721.0294,891,928.95
补充资料:
  净利润-59,836,360.14--101,328,265.58-
  资产减值准备27,993,162.86-74,607,095.35-
  固定资产和投资性房地产折旧79,148,062.53-162,371,027.91-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧79,148,062.53-162,371,027.91-
  无形资产摊销3,561,673.36-7,665,708.94-
  长期待摊费用摊销785,937.33-514,644.6-
  处置固定资产、无形资产和其他长期资产的损失162,577.53--63,568.85-
  固定资产报废损失517,806.54-24,012.12-
  财务费用16,440,407.35-30,979,212.2-
  投资损失-4,091,379.24--13,056,536.28-
  递延所得税3,638,470.44--5,034,295.27-
  其中:递延所得税资产减少3,732,765.02--4,933,156.51-
    递延所得税负债增加-94,294.58--101,138.76-
  存货的减少106,271,263.38-4,768,197.3-
  经营性应收项目的减少-77,640,828.4--23,628,677.9-
  经营性应付项目的增加-33,280,121.09-52,031,264.14-
  现金的期末余额208,359,460.11-155,489,721.02-
  减:现金的期初余额155,489,721.02-180,133,504.51-
  现金及现金等价物的净增加额52,869,739.09--24,643,783.49-
公告日期2025-08-262025-04-292025-04-292024-10-29
审计意见(境内)标准无保留意见
TOP↑